1. Identification of new drugs in small cell lung cancer: phase II agents first?;Aisner;Cancer Treat Rep,1987
2. Teniposide (VM26), an overlooked highly active agent in small cell lung cancer;Bork,1986
3. Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma;Jacobs;Cancer Treat Rep,1987
4. Phase II trial of mitoxantrone as first-line chemotherapy for extensive small cell lung cancer;Malik;Cancer Treat Rep,1987
5. Testing new drugs in untreated small cell lung cancer may prejudice the results of standard treatment: a phase II study of oral idarubicin in extensive disease;Cullen;Cancer Treat Rep,1987